169 related articles for article (PubMed ID: 15700837)
21. Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case report.
Nguyen TH; Pham T; Strickland T; Brewer D; Belirgen M; Al-Rahawan MM
Medicine (Baltimore); 2018 Sep; 97(39):e12477. PubMed ID: 30278534
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease.
Weil RJ; Lonser RR; DeVroom HL; Wanebo JE; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):95-105. PubMed ID: 12546357
[TBL] [Abstract][Full Text] [Related]
23. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
24. Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels.
Sundblom J; Skare TP; Holm O; Welin S; Braun M; Nilsson P; Enblad P; Sjöström EO; Smits A
PLoS One; 2022; 17(11):e0278166. PubMed ID: 36441756
[TBL] [Abstract][Full Text] [Related]
25. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
[TBL] [Abstract][Full Text] [Related]
26. Integra Foundation Award: Long-term natural history of hemangioblastomas in Von Hippel-Lindau disease: implications for treatment.
Ammerman JM; Lonser RR; Dambrosia J; Butman JA; Oldfield EH
Clin Neurosurg; 2006; 53():324-31. PubMed ID: 17380770
[No Abstract] [Full Text] [Related]
27. Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome.
Takai K; Taniguchi M; Takahashi H; Usui M; Saito N
Neurol Med Chir (Tokyo); 2010; 50(7):560-7. PubMed ID: 20671381
[TBL] [Abstract][Full Text] [Related]
28. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
[TBL] [Abstract][Full Text] [Related]
29. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
30. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
31. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
32. Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome.
Pavesi G; Feletti A; Berlucchi S; Opocher G; Martella M; Murgia A; Scienza R
J Neurosurg Sci; 2008 Jun; 52(2):29-36. PubMed ID: 18500215
[TBL] [Abstract][Full Text] [Related]
33. Review of the Neurological Implications of von Hippel-Lindau Disease.
Dornbos D; Kim HJ; Butman JA; Lonser RR
JAMA Neurol; 2018 May; 75(5):620-627. PubMed ID: 29379961
[TBL] [Abstract][Full Text] [Related]
34. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
35. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group.
Richard S; Campello C; Taillandier L; Parker F; Resche F
J Intern Med; 1998 Jun; 243(6):547-53. PubMed ID: 9681857
[TBL] [Abstract][Full Text] [Related]
36. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
37. [Recent advance in von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):212-5. PubMed ID: 20450775
[No Abstract] [Full Text] [Related]
38. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
39. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Migliorini D; Haller S; Merkler D; Pugliesi-Rinaldi A; Koka A; Schaller K; Leemann B; Dietrich PY
CNS Oncol; 2015; 4(6):387-92. PubMed ID: 26497655
[TBL] [Abstract][Full Text] [Related]
40. Pediatric central nervous system hemangioblastomas: different from adult forms? A retrospective series of 25 cases.
Cheng J; Liu W; Hui X; Zhang S; Ju Y
Acta Neurochir (Wien); 2017 Sep; 159(9):1603-1611. PubMed ID: 28752202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
